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Background With expansion of more advanced clinical roles for pharmacists we need to be mindful that the extent 21 
to which clinical pharmacy services (CPS) are implemented varies from one country to another. To date no 22 
comprehensive assessment of number and types of CPS provided by either community or hospital pharmacies in 23 
Austria exists. 24 
Objective To analyse and describe the number and types of CPS provided in both community and hospital 25 
pharmacies, as well as the level of clinical pharmacy education of pharmacists across Austria.   26 
Setting Austrian community and hospital pharmacies  27 
Method An electronic questionnaire to determine number and types of CPS provided was issued to all chief 28 
pharmacists at all community (n=1365) and hospital pharmacies (n=40) across Austria. Besides current and future 29 
CPS provision, education and training provision were determined.  30 
Main outcome measure Extent of and attitude towards CPS in Austria 31 
Results Response rates to the surveys were 19.1% (n=261/1365) in community and 92.5% (n=37/40) in hospital 32 
pharmacies. 59.0% and 89.2% of community and hospital pharmacies, respectively, indicated that CPS provision 33 
has increased substantially in the past 10 years. 51.0% of community pharmacies reported to provide a medication 34 
review service, while 97.3% of hospitals provide a range of CPS. Only 18.0% of community pharmacies offer 35 
services other than medication review services at dispensing. Binary regressions show that provision of already 36 
established medication management is a predictor for the willingness of community pharmacists to extend the 37 
range of CPS (p < 0.01), while completed training in the area of clinical pharmacy is not (p > 0.05). More hospital 38 
than community pharmacists have postgraduate education in clinical pharmacy (17.4% vs 6.5%). A desire to 39 
complete postgraduate education was shown by 28.3% of community and 14.7% of hospital pharmacists. Lack of 40 
time, inadequate remuneration, lack of resources and poor relationship between pharmacists and physicians were 41 
highlighted as barriers. 42 
Conclusion Both community and hospital pharmacists show strong willingness to expand their CPS provision and 43 
will need continued support, such as improved legislative structures, more supportive resources and practice 44 
focused training opportunities, to further these services. 45 
 46 
Impacts on practice 47 
• The current state of postgraduate training in clinical pharmacy and the pharmacists’ willingness for further 48 
education in this area show that additional training possibilities need to be established to strengthen the provision 49 
of CPS in Austria. 50 
• Although the findings of this survey suggest that the provision of CPS has been increased over the last years, 51 
there is still a significant lack of CPS in community pharmacies compared to other countries, such as the UK. 52 
• Since only 15% of hospitals have a hospital pharmacy department, the pharmacy workforce needs to be 53 
dramatically increased, in order to offer CPS nationwide. 54 




Introduction  57 
In 2017 the newly elected Austrian government included provision of enhanced pharmaceutical care services into 58 
their government strategy for the very first time in history [1]. This is driving policy change which supports the 59 
provision of advanced clinical roles for pharmacists in practice.  60 
The extent to which clinical pharmacy services (CPS) are implemented varies greatly from one country to another 61 
[2]. Especially in the USA, Canada, the United Kingdom and Australia, pharmaceutical care and CPS are well 62 
established compared to some European countries [3-6]. The benefits and positive patient outcomes associated 63 
with provision of CPS in both hospital and community pharmacies are well documented [7-17]. However, further 64 
evidence showing the value of CPS in the Austrian healthcare context is needed [18]. 65 
The annual report 2018, published by the Austrian Chamber of Pharmacists, lists over 1.360 community 66 
pharmacies and 40 hospital pharmacies (pharmacy department of veterinary hospital excluded), which implies 67 
that only about 15% of 269 hospitals have a hospital pharmacy department [19]. Community pharmacies in Austria 68 
are all privately owned, no pharmacy chains are allowed and remuneration is product-based. In the absence of 69 
reimbursement and a clear official mandate to provide CPS, the provision is self-motivated and down to the 70 
individual pharmacy to provide. The provision of more patient oriented CPS started about two decades ago. Today, 71 
CPS are largely part of the competences and responsibilities of Austrian hospital pharmacists [20]. In addition, 72 
pilot projects looking at providing CPS in community pharmacies have been ongoing. One example is the 73 
Pharmaceutical Safety Belt study, which took place in 71 community pharmacies in the federal state of Salzburg 74 
from 2007 to 2008 and looked at the prevention of adverse drug reactions, polypharmacy and the improvement of 75 
adherence [21]. This was the first project of its kind in Austria and it showed the need for CPS. 76 
Most recently more than one third of all community pharmacies were registered as participating pharmacies in a 77 
Medication Management Project run by the Austrian Chamber of Pharmacists [22]. The project aimed to provide 78 
participants with basic skills to complete a medication review within the community pharmacy with support from 79 
an expert board of clinical pharmacists at the Chamber of Pharmacists in Austria. A second pilot project, the 80 
Multiprofessional Geriatric Medication Management (GEMED) study, saw the establishment of medication 81 
management in eleven care homes [23]. As delivery of CPS is not supported by a designated remuneration 82 
structure, the level of services provided vary greatly from one pharmacy to another. Aside from a multinational 83 
EAHP survey and a report commissioned by the Austrian Federal Ministry of Health including case studies on 84 
pharmaceutical care, there is only very limited data on the extent to which CPS are implemented across the 85 
Austrian hospital and community pharmacy sector [21, 24-26]. A recent article comparing the development of 86 
CPS in 12 countries suggested a low degree of implementation of these services in Austrian community 87 
pharmacies [6].   88 
This study seeks to collect data about number and type of CPS in the community and hospital setting, aiding 89 
assessment of current state of implementation of these services and supporting decision-making on a professional 90 





Aim of the study 94 
The aim of this study was to analyse and describe the number and types of CPS provided in both community and 95 
hospital pharmacies, as well as the level of clinical pharmacy education of pharmacists across Austria.   96 
 97 
Ethics approval 98 
The School of Pharmacy and Life Sciences at Robert Gordon University Aberdeen and the ethics board of the city 99 
of Vienna advised that this study did not require formal review by an ethics committee. 100 
 101 
Methods 102 
Two pilot questionnaires (community/hospital pharmacy) were designed in accordance with published best 103 
practice and current scientific work conducted by the European Association of Hospital Pharmacists (EAHP) 104 
(Table 1; Appendix) [26, 27]. The questionnaires were reviewed for face and content validity by six research 105 
experienced hospital and eight community pharmacists across different federal states in Austria. The 106 
questionnaires were piloted in around 10% (community n=138; hospital n=6) of the final sample size and 107 
adjustments were made. The questionnaire contained five sections with a mixture of open and closed questions. 108 
Sections on background information, education and training, current and future provision of CPS, as well as an 109 
open question for pharmacists to voice their professional opinion were included (Table 1). In April 2018, the 110 
Austrian Chamber of Pharmacists sent the final online questionnaire survey to all community (n=1365) and 111 
hospital (n=40) pharmacies across Austria, asking chief pharmacists for completion. Two reminders were sent at 112 
four-weekly intervals, published via the Austrian Pharmaceutical Journal and their online bulletin board. Data 113 
was coded and entered into SPSS for Windows vs. 21 (SPSS Inc.) and analysed using descriptive statistics, binary 114 
regression analysis (p < 0.05) and non-parametric statistical tests where appropriate (Kruskal-Wallis test). Content 115 
analysis was performed on the responses to open questions relating to personal opinions and experiences with 116 
provision of CPS [28]. Key themes are described using illustrative quotes with each respondent assigned a number.  117 
 118 
Results 119 
The responses of 261 community pharmacies (19.1% response rate; n=261/1365) and 37 hospital pharmacies 120 
(92.5% response rate; n=37/40) were included in this analysis. Demographic data are given in Table 2.  121 
 122 
Community Pharmacies 123 
Current provision of CPS 124 
A medication review service is the most frequently provided CPS in community pharmacy according to 125 
respondents (Table 3). Answers to open questions show that many community pharmacies implemented 126 
medication review services after completion of the continuous professional development (CPD) course on 127 
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medication reviews offered by the Austrian Chamber of Pharmacists. “We started offering medication reviews 128 
after successful completion of the courses” [P037]. They see continued need for medication review services going 129 
forward. “Remunerated medication reviews in all patients with polypharmacy“[P017]; “medication reviews over 130 
the counter” [P034]; Medication reviews for nursing homes and sheltered housing units [….]” [P083]. 131 
Remuneration, time, working relationship with physicians and appropriate computer software are seen as biggest 132 
barriers to successful continuation and extension of medication review services. “To support medication review 133 
services we need a useful free of charge database for all pharmacies” [P074]. 134 
Only 18% (n=47) of participating community pharmacies offer other clinical services (Table 3). The respondents 135 
provided a diverse list of additional service(s) including “Filling compliance aids [P048]”; “Screening HbA1c, 136 
blood pressure, cholesterol [P135]”; “Interpretation of and counselling on the basis of pharmacogenetic analysis 137 
[P065]” and “Nursing home support for medication related questions [P115]”. 59.0% (n=154) of respondents 138 
confirmed having extended CPS in the past 10 years largely being a result of CPD-programs offered by the 139 
Austrian Chamber of Pharmacists (Table 3). 26.8% (n=70) of participating pharmacies state that they document 140 
CPS routinely (Table 3). Most of them document in paper form (n=59). 141 
Future provision of CPS 142 
More than two-thirds of respondents (69.0%; n=180) show a desire to extend the range of CPS (Table 3). Binary 143 
regression analysis shows that this is independent of age (p > 0.05) or number of pharmacists working within a 144 
community pharmacy (p > 0.05). Completion of a postgraduate degree or CPD-programme is also not a predictor 145 
for the willingness to extend CPS (p > 0.05). Community pharmacists who have an already established medication 146 
management service are most willing to extend their range of services (p < 0.01). In addition, statistical 147 
contingency tables indicate that community pharmacists who have already extended CPS are not only more 148 
willing to extend these further but would like a more professional relationship with physicians. “Closer working 149 
relationships with physicians (to show our breadth of competence) [P031]”. One pharmacist even considers that 150 
“[…] a clinical pharmacist could become a job title in its own right, they would work independently running their 151 
own clinic” [P195].  152 
Clinical Pharmacy education and training  153 
9.1% (n=94) of pharmacists have successfully completed or are in the process of completing a postgraduate degree 154 
or CPD-programme in clinical pharmacy (Table 4). 28.3% (n=294) of community pharmacists have a desire to 155 
complete such a postgraduate education in the future (Table 4). Open responses show that Austrian community 156 
pharmacists would welcome a much wider range of education and training programmes for qualified pharmacists 157 
“more education programmes for Austrian pharmacists please” [P042]; “postgraduate degrees and 158 
PgCertificate programmes” [P073]. It is of special interest to respondents that the level of education is appropriate 159 
“Education programmes should be building on each other not offer a simple repeat, foster networking […]” 160 
[P006] and that clinical pharmacy is seen as a key competency for all pharmacists. “Clinical pharmacy = key 161 
competence of every pharmacist, instead of offering additional programmes we need to highlight that everyone 162 
who has obtained his/her license is (or should) also be qualified as a clinical pharmacist” [P006]. Suggestions 163 
for the future include mandatory continuing professional development and introducing concepts of clinical 164 
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pharmacy in the undergraduate curriculum. The willingness to complete an additional postgraduate education 165 
programme is independent of age (p > 0.05; Kruskal-Wallis test). 166 
 167 
Hospital Pharmacies 168 
Current provision of CPS 169 
As reported by participating hospital pharmacists, CPS have been extended in the past 10 years in almost all 170 
participating hospitals (89.2%; n=33) (Table 5) with 97.3% (n=36) providing a CPS (Table 5). Participating 171 
hospital pharmacies have a workforce of 340 pharmacists or 300 full-time equivalents (FTE). Currently, only 14% 172 
(n=42 FTE) of the pharmacist-workforce is used to deliver CPS services routinely. 173 
The two most commonly provided services are ward-based CPS (83.8%; n= 31) and/or the provision of a dedicated 174 
medicines information service to other healthcare professionals (54.1%; n=20). The ward pharmacist services are 175 
mainly delivered daily (32.4%; n=12) or weekly (43.2%; n=16) with orthopaedics, surgery, geriatrics and internal 176 
medicine the most frequently covered clinical specialties (Table 5). Most of CPS are offered at the point of patient 177 
admission (43.2%; n=16) focusing on medication review (40.5%; n=15) and reconciliation (35.1%; n=13). Only 178 
8.1% (n=3) of the hospitals also offer CPS at the point of discharge (Table 5). 179 
The value of these services is widely acknowledged by the respondents and they express a strong wish for 180 
extension. “Extension of existing CPS to more departments; shifting focus from “passive” activities (we visit the 181 
ward and deliver a service) to handling of more active inquiries (focused medication reviews) or needs (screening 182 
of selected medication histories on admission)” [P039]. As reported by participating hospital pharmacists, the 183 
interest in extension of ward-based CPS is supported by both physicians and nurses (86.5%; n=32who would 184 
welcome the extension of multidisciplinary team meetings, ward rounds, admission and discharge services as well 185 
as medication reviews for inpatients. This would however require a considerable investment in staff resources (“If 186 
we had more staff we could do much more” [P043]). Other than lack of staff, lack of adequate training, electronic 187 
patient records and legislative structures were seen as main barriers to extend CPS. 188 
89.2% (n=33) of all participating hospital pharmacies state that they document all or almost all of their suggested 189 
clinical interventions routinely. 62.2% (n=23) use a validated classification system for the documentation of all 190 
or almost all of their clinical pharmacists’ interventions. In most cases this is based on the French society for 191 
clinical pharmacy tool (29.7%; n=11) (Table 5) [29]. 192 
Future provision of CPS 193 
Almost all respondents (94.6%; n=35) show desire for extension of CPS (Table 5). In addition to suggested 194 
extension opportunities for clinical admission-/discharge services and specialist ward-based pharmacy input, 195 
participants suggest improved legislative structures, more supportive resources and practice focused training 196 
opportunities. “Legislative structures, without them an extension of services will be very difficult” [P005]; 197 
“Increase in staff resources (it is no longer possible to achieve this using rationalisation strategies); Software 198 
support; integration of systems would be useful” [P028]; “Undergraduate curriculum has to become more 199 
practice focused. Rotation in hospital; Placements in other hospitals; more postgraduate opportunities” [P029]. 200 
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Clinical pharmacy education and training  201 
More than half of all pharmacists in participating hospitals have or are in the process of completing a postgraduate 202 
specialisation in hospital pharmacy practice (66.5%; n=226) (Table 4). 18.8% (n=64) pharmacists either have or 203 
are in the process of obtaining a postgraduate degree in clinical pharmacy practice (Table 4). In addition, 14.7% 204 
(n=50) of pharmacists are interested in completing such a qualification in the future. Open questions reflect a 205 
desire for better integration of clinical pharmacy into the undergraduate curriculum including placement 206 
opportunities. „Better integration into the curriculum, clinical topics“[P024]. 207 
 208 
Discussion 209 
To our knowledge this is the first large national study reporting number and types of CPS provided in community 210 
and hospital pharmacies across Austria. In general, the provision of CPS across both sectors has expanded over 211 
the past 10 years and there is desire for further expansion. Focus of these services is mainly centred on medication 212 
reviews and medication management in both settings. While lack of adequate training was a concern of both 213 
sectors, community and hospital pharmacists named different barriers towards implementation and extension of 214 
CPS. Community pharmacists highlighted lack of time, inadequate remuneration, lack of resources and an often-215 
poor relationship between pharmacists and physicians as main barriers to implementation of CPS. In hospital 216 
pharmacies, lack of staff was named as main barrier with additional identified barriers such as lack of electronic 217 
patient records and legislative structures. Besides CPS, Austrian hospital pharmacists are responsible for other 218 
tasks, such as strategic procurement, logistics, sterile/non-sterile production and compounding [30]. 219 
The majority of participating community pharmacists indicated that CPS have been extended over the past decade 220 
with a particular emphasis on implementation of medication reviews. Martins et al. reported that two-thirds of 221 
European countries offered pharmaceutical care programmes with medication reviews as an integral part [31]. 222 
Our findings place Austria in line with other European countries. While the study looked at establishing the types 223 
of services available in community pharmacy across 27 European countries, using a quantitative survey 224 
methodology, Austria was not included in the analysis and therefore care needs to be taken when extrapolating 225 
the findings [31]. Still this is an encouraging result and highlights that training provided by the Austrian Chamber 226 
of Pharmacists has been supportive to implement review services which have increased in prevalence over the 227 
past decade.  228 
Participants in this study expressed a desire to complete postgraduate education in the future. The fact that 229 
willingness to extend CPS was dependent on already implemented medication management services but not on 230 
completed training, shows that creation of an environment in which pharmacists can perform clinical tasks is vital.   231 
Previous research showed a statistically significant correlation between lack of skill to perform medication 232 
assessments and lack of vision on professional development [32]. As pharmacists’ education has been identified 233 
as a key barrier to implementation of CPS, it is very encouraging that Austrian pharmacists understand the need 234 
to acquire the necessary skillset to progress CPS offered [32]. 235 
As known from an Austrian pilot-project, where up to one third of all community pharmacies participated, the 236 
number of medication reviews performed by each pharmacy was mostly in the single-digit range [22]. Density of 237 
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medication review services carried out in pharmacies thus still lags significantly behind countries such as the UK 238 
[33]. However, this is not surprising as regulatory change and implementation of reimbursed medication reviews 239 
as a mandatory element in the community pharmacy contract assisted in increasing CPS in the UK [34].  240 
In contrast to community pharmacies, this study identified that almost all Austrian hospital pharmacies provide 241 
CPS to various degrees of implementation. A comparison of the findings with the EAHP surveys [24-26] shows 242 
that the number of CPS carried out on admission increased (2010: 17.1%; 2018: 43.2%) while the number at 243 
discharge stayed nearly unchanged (2010: 8.6%; 2018: 8.1%). The percentage of hospital pharmacies 244 
documenting clinical activities has increased with the majority of hospitals using a validated classification system 245 
such as adapted versions of the French Society of Clinical Pharmacy tool [29]. This documentation allows drug-246 
related problems and suggested interventions to be tracked and analysed, ultimately allowing assessment of the 247 
pharmacists’ contribution to patient care.  248 
Barriers to implementation of pharmaceutical care are well documented around the world [2, 35-39]. Lack of 249 
financial resources, time, software support, education, staff and the healthcare structure itself have been identified 250 
as key barriers for many years [35]. While results from this study echo these global concerns, physician’s attitude 251 
was seen as a main barrier in community pharmacies, whereas hospital pharmacists claimed that hospital-based 252 
physicians would support the extension of CPS. This disparity may be attributed to experiences with 253 
interdisciplinary working in hospitals, compared to the more insular working environment in the community 254 
setting. Studies have shown that pharmacists need to establish trustworthiness and clarification of their clinical 255 
roles to build a collaborative working relationship with medical healthcare professionals. As benefits of 256 
pharmacists’ involvement become more apparent to medical healthcare professionals, closer working 257 
relationships are likely to develop [40, 41]. In Austria, more resources need to be invested in supporting 258 
pharmacists to work in multidisciplinary environments both within the hospital and community practice setting 259 
to ensure long-term success of CPS. 260 
The results of our study emphasise both the willingness of the pharmacists and the need for further implementation 261 
of CPS across Austria. Findings presented, clearly show progress in provision of CPS across Austria over the last 262 
decade. Dedicated support and implementation of structures should allow continuous and sustainable development 263 
of these services in hospital and community pharmacies. 264 
Further research is necessary to explore facilitators and barriers towards implementation of CPS across both 265 
sectors, in order to implement a framework for CPS. Evaluating all documented CPS and the establishment of 266 
quality assurance measures would be beneficial to show and guarantee the impact CPS are having on patient care 267 
across Austria.  268 
To our knowledge this is the first national study of its kind in Austria. The study provides data regarding state of 269 
implementation of CPS, which is important for political process and to support implementation of CPS through 270 
adequate remuneration. Due to the good response rate, especially for hospital pharmacies, reliability of the results 271 
can be assumed. 272 
However, the study has its limitations. The self-reported nature of the questionnaire does not allow verification of 273 
the responses. As the survey was answered by the manager or an authorised pharmacist, the opinion of employees 274 
might differ from received answers. The response rate of community pharmacies was low compared to hospital 275 
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pharmacies. It might be reasonably assumed that pharmacies with a positive attitude towards clinical pharmacy 276 
were more likely to participate in the survey, thus causing social desirability bias. Differences in perception and 277 
definition of the term “clinical pharmacy” might be a further limitation of the study. This could either lead to over- 278 
or underestimation, as services might not be recognized or mistakenly identified as such. Another limitation is 279 
that only hospitals with a hospital pharmacy department were used as a reference for the hospital pharmacy sector. 280 
However, due to the current situation in Austria, only hospitals with a hospital pharmacy department offer a 281 
realistic potential for implementation of CPS. 282 
 283 
Conclusion 284 
This self-reported survey shows that CPS provision in Austria has been on the rise over the past decade and 285 
pharmacists are eager to continue their implementation across both community and hospital pharmacy sector. 286 
Support is needed to overcome identified barriers and provide a sustainable implementation structure alongside a 287 
range of postgraduate education opportunities. Pharmacists across Austria are setting a clear signal that they 288 
consider CPS to be a key aspect of their professional role in the future. 289 
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Tables and Figures 405 
Table 1 Overview and structure of the questionnaire which was sent to community and hospital pharmacies in 406 
Austria. 407 
 408 
Section Question topics included 
Background Information • Federal state 
• Job role of participant 
• Number of pharmacists in each pharmacy 
• Average age of all employed pharmacists 
Education and Training • Number and type of education and training completed:  
specialist postgraduate programmes 
continuous professional development (CPD) programmes in clinical 
and/ or hospital pharmacy 
• Number and type of pharmacists interested in such an education 
Current provision of clinical pharmacy 
services 
• Medication reviews 
• Number and type of other services offered 
• Documentation type and frequency 
Future provision of clinical pharmacy 
services 
• Desire  
• Feasibility 
• Types of services anticipated 
Open question • Professional opinion and experiences with the provision of clinical 
pharmacy services 
 409 
  410 
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Table 2 Demographic data from 261 community pharmacies and from 37 hospital pharmacy respondents across 411 













Federal state                                                             
 
Burgenland 6 (2.3) 2 (5.4) 
Niederösterreich 43(16.5) 3 (8.1) 
Kärnten 15(5.7) 3 (8.1) 
Oberösterreich 53 (20.3) 10 (27) 
Salzburg 16 (6.1) 1 (2.7) 
Steiermark 36 (13.8) 5(13.5) 
Tirol 22 (8.4) 1 (2.7) 
Vorarlberg 19 (7.3) 1 (2.7) 
Wien 50 (19.2) 11 (29.7) 
No response  1 (0.4) 0 (0.0) 
 
Role of 
Participant                                                                    
 
Manager 
(Pharmacy) 260 (99.6) 27 (73) 
Employee 
Pharmacist 0 (0) 10 (27) 









per Pharmacy  
 
1 4 (1.5) 0 (0) 
2 29 (11.1) 2 (5.4) 
3 80 (30.7) 5 (13.5) 
4 76 (29.1) 2 (5.4) 
5 38 (14.6) 1 (2.7) 
6 9 (3.4) 2 (5.4) 
7 10 (3.8) 3 (8.1) 
8 4 (1.5) 5 (13.5) 
9 1 (0.4) 3 (8.1) 
10 2 (0.8) 3 (8.1) 
> 10 4 (1.5) 10 (27.0) 
No response 4 (1.5) 1 (2.7) 
 413 
  414 
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Table 3 Responses on the provision of clinical pharmacy services from 261 community pharmacy respondents 415 
across Austria.  416 
Provision of clinical pharmacy services in community pharmacies 







Are you providing 
medication reviews as part 
of a medication management 
program at your pharmacy 
Yes 133 (51.0) 30 (11.5) 
No 98 (37.5) 
Are there any other clinical 
pharmacy services provided 
(going beyond drug 
information on a daily basis) 
in your pharmacy? 
Yes 47 (18.0) 43 (16.5) 
No 171 (65.5) 
Are clinical pharmacy 
services documented? 
Yes 70 (26.8) 37 (14.2) 
No 154 (59.0) 
What kind of documentation 
do you use? 







Paper form 59 (22.6) 
Not applicable  93 (35.6) 
Have the clinical pharmacy 
services been expanded 
compared to 10 years ago? 
Yes 154 (59.0) 38 (14.6) 
No 69 (26.4) 
Are you interested in 
expanding clinical pharmacy 
services? 
 
Yes 180 (69.0) 48 (18.4) 




  420 
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Table 4: Responses on education from 261 community pharmacy (= 1038 pharmacists in total) and from 37 421 
hospital pharmacy (= 340 pharmacists in total) respondents across Austria.  422 
Education 














How many pharmacists 
have completed training / 
further education in the 
field of clinical pharmacy 
(postgraduate studies, 
certificate courses lasting 








13 (3.8) 3 (0.9) 
Certificate course 39 (3.8) Certificate 
course 
42 (12.4) 
Other 11 (1.1) Other 4 (1.2) 
How many pharmacists 
are currently undergoing 





15 (1.4) Postgraduate 
studies 
4 (1.2) 
Certificate course 5 (0.5) Certificate 
course 
1 (0.3) 
Other 7 (0.7) Other 0 (0.0) 
How many pharmacists 




105 (10.1) Postgraduate 
studies 
22 (6.5) 
Certificate course 135 (13.0) Certificate 
course 
23 (6.8) 
Other 54 (5.2) Other 5 (1.5) 
How many pharmacists 
have or are currently 
undergoing a 
postgraduate 
specialisation in hospital 
pharmacy practice? 




157 (46.2) 22 (6.5) 
 




  424 
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Table 5 Responses on the provision of clinical pharmacy services from 37 hospital pharmacy respondents 425 
across Austria.  426 
Provision of clinical pharmacy services in hospital pharmacies 









pharmacy services at 
your hospital? 
Yes 36 (97.3) 1 (2.7) 
No 0 (0.0)  
Are the clinical 
pharmacy services 
delivered ward-based? 
Yes  31 (83.8) 1 (2.7) 
 No 5 (13.5) 





Daily 12 (32.4) 
Weekly 16 (43.2) 
Fortnightly 2 (5.4) 
Monthly 1 (2.7) 
Other  4 (10.8) 
Not applicable 1 (2.7) 
Does your pharmacy 
offer a dedicated 
medicines information 
service?  
Yes 20 (54.1) 2 (5.4) 
No 15 (40.5) 
Are clinical pharmacy 
services offered at the 
point of admission? 
Yes 16 (43.2) 2 (5.4) 
 No 19 (51.4) 
Which clinical 
pharmacy services are 







Medication review 15 (40.5) 
Other  6 (16.2) 
Are clinical pharmacy 
services offered at the 
point of discharge? 
Yes 3 (8.1) 2 (5.4) 
No 32 (86.5) 
Are clinical pharmacy 
services documented? 
All 26 (70.3) 2 (5.4) 
 Almost 7 (18.9) 
Partially 1 (2.7) 
Infrequently 0 (0.0) 
Never 1 (2.7) 
Not applicable  0 (0.0) 
Do you use a validated 
classification system? 
All 14 (37.8) 
Almost 9 (24.3) 
Partially 4 (10.8) 
Infrequently 0 (0.0) 
Never 0 (0.0) 
Not applicable 8 (21.6) 
Which kind of 
classification system 
do you use? 
Based on French 
Society of Clinical 
Pharmacy Tool 
11 (29.7) 
Based on PCNE 1 (2.7) 
Other 16 (43.2) 
None 7 (18.9) 
Have the clinical 
pharmacy services 
been expanded 
Yes 33 (89.2) 2 (5.4) 
No 2 (5.4) 
17 
 
compared to 10 years 
ago? 
 




Yes 35 (94.6) 2 (5.4) 
No 0 (0.0) 




Yes 32 (86.5) 3 (8.1) 










Please select the federal state  




How many pharmacists (including the 
pharmacy manager) work in your 
pharmacy?  
Number 
Please provide the number of 





Training and Education 
How many pharmacists have a 
completed training in the area of 
clinical pharmacy (e.g. postgraduate 




How many pharmacists are currently 







How many pharmacists are interested 






Hospital pharmacy section: 
How many pharmacists have a 
postgraduate specialisation in hospital 
pharmacy practice?  
Number 
Hospital pharmacy section: 
How many pharmacists are currently 
undergoing a postgraduate 
specialisation in hospital pharmacy 
practice?  
Number 
Clinical pharmacy services 
Community pharmacy section: 
Are you providing medication reviews 
as part of a medication management 
program at your pharmacy? 
Yes/No 
Community pharmacy section: 
Are there any other clinical pharmacy 
services provided (going beyond drug 





Community pharmacy section: 
Which kind of other clinical pharmacy 
services are provided? 
Free text 
Hospital pharmacy section: 
Are pharmacists providing clinical 
pharmacy services at your hospital? 
Yes/No 
Hospital pharmacy section: 
How many FTE of the overall 
pharmacist workforce are used to 
deliver clinical pharmacy services?  
Number 
Hospital pharmacy section: 







Which clinical specialities are covered? 
Hospital pharmacy section: 
Are clinical pharmacy services offered 
at the point of admission? 
Yes/No 
 
Which services are provided?  
Medicines reconciliation/Medication 
review/Other 
Hospital pharmacy section: 
Are clinical pharmacy services offered 
at the point of discharge? 
Yes/No 
 
Hospital pharmacy section: 
Does your pharmacy offer a dedicated 
medicines information service? 
Yes/No 
Documentation 
Are clinical pharmacy services 
documented? 
Community pharmacy section: 
Yes/No 
Electronic patient record/Other electronic 
documentation/Paper form/Not applicable 
 
Hospital pharmacy section: 
All/Almost all/Partially/Infrequently/Never 
Use of a validated classification system: 
All/Almost all/Partially/Infrequently/Never 
Which kind of classification system is used: 
Based on French Society of Clinical Pharmacy 
Tool/Based on PCNE/Other/None 
Review and outlook 
Have clinical pharmacy services been 
extended over the past 10 years? 
Yes/No 
 
Which kind of extension was made? 




Hospital pharmacy section: 
Interest from pharmacists/physicians and 
nurses? 
 
Further ideas regarding clinical pharmacy  
3 
 
Further ideas regarding clinical 
pharmacy? 
 
 
 
 
